HomeAVXL • NASDAQ
add
Anavex Life Sciences Corp
Previous close
$9.58
Day range
$9.33 - $9.69
Year range
$5.03 - $14.44
Market cap
804.83M USD
Avg Volume
1.00M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 14.33M | 1.81% |
Net income | -13.24M | -8.42% |
Net profit margin | — | — |
Earnings per share | -0.16 | -14.29% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 101.16M | -27.09% |
Total assets | 102.43M | -27.63% |
Total liabilities | 11.47M | -2.38% |
Total equity | 90.96M | — |
Shares outstanding | 85.89M | — |
Price to book | 9.04 | — |
Return on assets | -32.64% | — |
Return on capital | -37.57% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -13.24M | -8.42% |
Cash from operations | -12.46M | -140.62% |
Cash from investing | — | — |
Cash from financing | -2.14M | -147.10% |
Net change in cash | -14.61M | -2,218.57% |
Free cash flow | -10.44M | -492.16% |
About
Founded
2004
Headquarters
Website
Employees
42
